MII IG Kerndatensatz-Modul Onkologie
2027.0.0-ballot.1 - Germany

This page is part of the MII IG Kerndatensatz-Modul Onkologie (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example MedicationStatement: Oxaliplatin Phase 1 (Zyklen 1-6, dann abgebrochen)

English

basedOn: CarePlan: identifier = Tumorkonferenz_FOLFOX_Modification_001; status = active; intent = plan; category = prätherapeutische Tumorkonferenz (Festlegung der Therapiestrategie); created = 2024-03-05

partOf: Procedure Nicht komplexe Chemotherapie

status: Stopped

statusReason: Grade 3 peripheral neuropathy (CTCAE) - cumulative neurotoxicity from oxaliplatin

medication: Oxaliplatin

subject: Martin Beispiel Male, DoB: 1958-11-03

effective: 2024-03-15 --> 2024-06-10

note:

FOLFOX4 - Cycles 1-6 only. Discontinued due to severe peripheral neuropathy. Patient experienced numbness and tingling in hands and feet (grade 3 CTCAE), interfering with daily activities.